Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 23, 2015View HTMLDownload DOCDownload PDFDownload XLS
DEFA14AAdditional proxy soliciting materials - definitiveApr 23, 2015View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 3, 2015View HTMLDownload DOCDownload PDF
8-K/AAmendment to a previously filed 8-KApr 3, 2015View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 24, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 18, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 11, 2015View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMar 6, 2015View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 5, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2015View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2015View HTMLDownload DOCDownload PDF
10-KAnnual report which provides a comprehensive overview of the company for the past yearMar 2, 2015View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventFeb 25, 2015View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-100      101-125      126-127

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information